Industry: Machinery & Equipment
Published Date: 2026-03-26
Pages: 110 Pages
Report ld: 6332210
Request Sample
Customized Report
Biolayer Interferometry (BLI) Instruments Market Size(US$)

CAGR 2026-2032
8.1%
Market Size,2032
USD 161
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biolayer Interferometry (BLI) Instruments market is projected to grow from US$ 93.77 million in 2025 to US$ 161 million by 2032, at a CAGR of 8.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Bio-Layer Interferometry (BLI) Instruments are advanced optical biosensing devices that operate by detecting changes in the interference pattern of light reflected from a biosensor tip as biomolecular interactions occur on its surface. They enable real-time, label-free monitoring of various biomolecular binding events like protein-protein, protein-small molecule, or antibody-antigen interactions, offering high sensitivity and a wide detection range, and are widely utilized in fields such as drug discovery, antibody engineering, and biomedical research.
The Biolayer Interferometry (BLI) instruments market is experiencing significant growth, driven by increasing demand for label-free and real-time detection methods in biomedical research, drug development, diagnostics, and life sciences. BLI is a technique that monitors biomolecular interactions by measuring changes in the interference pattern of light reflected from a biosensor surface. The technique is non-invasive, highly sensitive, and doesn't require fluorescent or radioactive labels, making it attractive for various applications in molecular biology, biochemistry, and pharmaceutical development.
BLI is increasingly used in drug discovery and pharmaceutical development for studying interactions between biomolecules (e.g., proteins, nucleic acids, small molecules). The ability to measure binding kinetics, affinity, and concentration in real-time without the need for labeling has made BLI an essential tool in preclinical and clinical research.
Immunoassays, antibody-drug conjugates, and biologics are some of the key applications driving the demand for BLI systems. BLI helps researchers quickly assess the efficacy and binding properties of drug candidates.
One of the main advantages of BLI over other techniques like ELISA or surface plasmon resonance (SPR) is its ability to perform label-free detection and real-time monitoring of molecular interactions. This advantage is particularly important for high-throughput screening, where the speed and accuracy of data collection are critical.
The increased need for real-time data in applications such as biomarker discovery and therapeutic antibody development is contributing to the growing demand for BLI instruments.
BLI instruments are being utilized in bioprocessing to monitor interactions in biological systems and to optimize the production of biologic drugs. For example, BLI can help in monoclonal antibody production, ensuring that the produced antibodies meet required quality standards and reducing the time needed for quality control.
Real-time monitoring of the binding kinetics during fermentation or cell culture processes can lead to better process optimization, reduced costs, and increased yields.
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Biolayer Interferometry (BLI) Instruments market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Biolayer Interferometry (BLI) Instruments study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Biolayer Interferometry (BLI) Instruments: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biolayer Interferometry (BLI) Instruments Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Low and Medium Throughput
1.2.3 High Throughput
1.3 Market Segmentation by Application
1.3.1 Global Biolayer Interferometry (BLI) Instruments Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Drug Discovery
1.3.3 Antibody Engineering
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biolayer Interferometry (BLI) Instruments Revenue Estimates and Forecasts (2021-2032)
2.2 Global Biolayer Interferometry (BLI) Instruments Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Biolayer Interferometry (BLI) Instruments Sales Estimates and Forecasts (2021-2032)
2.4 Global Biolayer Interferometry (BLI) Instruments Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Biolayer Interferometry (BLI) Instruments Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032
3 Competitive Landscape
3.1 Global Biolayer Interferometry (BLI) Instruments Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Biolayer Interferometry (BLI) Instruments Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Low and Medium Throughput: Market Share by Key Manufacturers
3.6 Global Biolayer Interferometry (BLI) Instruments Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Biolayer Interferometry (BLI) Instruments Sales Performance by Type
4.1.1 Global Biolayer Interferometry (BLI) Instruments Sales Volume by Type (2021-2032)
4.1.2 Global Biolayer Interferometry (BLI) Instruments Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Biolayer Interferometry (BLI) Instruments Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biolayer Interferometry (BLI) Instruments Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 Global Production Analysis
6.1 Global Biolayer Interferometry (BLI) Instruments Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 China
6.3.4 Japan
7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Biolayer Interferometry (BLI) Instruments Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Biolayer Interferometry (BLI) Instruments Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Biolayer Interferometry (BLI) Instruments Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Biolayer Interferometry (BLI) Instruments Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Biolayer Interferometry (BLI) Instruments Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Biolayer Interferometry (BLI) Instruments Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Biolayer Interferometry (BLI) Instruments Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Biolayer Interferometry (BLI) Instruments Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Biolayer Interferometry (BLI) Instruments Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Biolayer Interferometry (BLI) Instruments Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa
12 Corporate Profile
12.1 Sartorius
12.1.1 Sartorius Corporation Information
12.1.2 Sartorius Business Overview
12.1.3 Sartorius Biolayer Interferometry (BLI) Instruments Product Models, Descriptions and Specifications
12.1.4 Sartorius Biolayer Interferometry (BLI) Instruments Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 Sartorius Biolayer Interferometry (BLI) Instruments Sales by Product in 2025
12.1.6 Sartorius Biolayer Interferometry (BLI) Instruments Sales by Application in 2025
12.1.7 Sartorius Biolayer Interferometry (BLI) Instruments Sales by Geographic Area in 2025
12.1.8 Sartorius Biolayer Interferometry (BLI) Instruments SWOT Analysis
12.1.9 Sartorius Recent Developments
12.2 Gator Bio
12.2.1 Gator Bio Corporation Information
12.2.2 Gator Bio Business Overview
12.2.3 Gator Bio Biolayer Interferometry (BLI) Instruments Product Models, Descriptions and Specifications
12.2.4 Gator Bio Biolayer Interferometry (BLI) Instruments Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Gator Bio Biolayer Interferometry (BLI) Instruments Sales by Product in 2025
12.2.6 Gator Bio Biolayer Interferometry (BLI) Instruments Sales by Application in 2025
12.2.7 Gator Bio Biolayer Interferometry (BLI) Instruments Sales by Geographic Area in 2025
12.2.8 Gator Bio Biolayer Interferometry (BLI) Instruments SWOT Analysis
12.2.9 Gator Bio Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Biolayer Interferometry (BLI) Instruments Industry Chain
13.2 Biolayer Interferometry (BLI) Instruments Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Biolayer Interferometry (BLI) Instruments Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Biolayer Interferometry (BLI) Instruments Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Biolayer Interferometry (BLI) Instruments Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs
15 Key Findings in the Global Biolayer Interferometry (BLI) Instruments Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biolayer Interferometry (BLI) Instruments market size was US$ 93.77 million in 2025 and is forecast to reach a readjusted size of US$ 161 million by 2032 with a CAGR of 8.1% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 75
USD 4250.00
(Single User License)
The global market for Biolayer Interferometry (BLI) Instruments was estimated to be worth US$ 93.77 million in 2025 and is projected to reach US$ 161 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 82
USD 3950.00
(Single User License)
The global Biolayer Interferometry (BLI) Instruments market was valued at US$ 93.77 million in 2025 and is anticipated to reach US$ 161 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 121
USD 2900.00
(Single User License)
The global market for Biolayer Interferometry (BLI) Instruments was estimated to be worth US$ 86.6 million in 2024 and is forecast to a readjusted size of US$ 150 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 80
USD 3950.00
(Single User License)
The global Biolayer Interferometry (BLI) Instruments market is projected to grow from US$ 86.6 million in 2024 to US$ 150 million by 2031, at a CAGR of 8.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 116
USD 4900.00
(Single User License)
The global Biolayer Interferometry (BLI) Instruments market size was US$ 86.6 million in 2024 and is forecast to a readjusted size of US$ 150 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 66
USD 4250.00
(Single User License)
The global market for Biolayer Interferometry (BLI) Instruments was valued at US$ 86.6 million in the year 2024 and is projected to reach a revised size of US$ 150 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Published Date: 2025-03-10
Pages: 82
USD 2900.00
(Single User License)
Valued at US$ 93.8 million in 2024, the global Biolayer Interferometry (BLI) Instruments market is forecast to reach US$ 150 million by 2030, at a CAGR of 8.1% during the forecast period.
Published Date: 2025-03-03
Pages: 129
USD 4900.00
(Single User License)
Bio-Layer Interferometry (BLI) is a label-free, real-time monitoring optical detection technology, mainly used to analyze the interaction between biomolecules. BLI instruments detect the kinetic changes or concentration data of molecular interactions by monitoring the changes in the film thickness caused by the binding of biomolecules on the surface of the biosensor.
Published Date: 2024-09-04
Pages: 82
USD 2900.00
(Single User License)
Bio-Layer Interferometry (BLI) is a label-free, real-time monitoring optical detection technology, mainly used to analyze the interaction between biomolecules. BLI instruments detect the kinetic changes or concentration data of molecular interactions by monitoring the changes in the film thickness caused by the binding of biomolecules on the surface of the biosensor.
Published Date: 2024-09-04
Pages: 88
USD 3950.00
(Single User License)
The global Biolayer Interferometry (BLI) Instruments market size was US$ 93.77 million in 2025 and is forecast to reach a readjusted size of US$ 161 million by 2032 with a CAGR of 8.1% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 75
The global market for Biolayer Interferometry (BLI) Instruments was estimated to be worth US$ 93.77 million in 2025 and is projected to reach US$ 161 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 82
The global Biolayer Interferometry (BLI) Instruments market was valued at US$ 93.77 million in 2025 and is anticipated to reach US$ 161 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 121
The global market for Biolayer Interferometry (BLI) Instruments was estimated to be worth US$ 86.6 million in 2024 and is forecast to a readjusted size of US$ 150 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 80
The global Biolayer Interferometry (BLI) Instruments market is projected to grow from US$ 86.6 million in 2024 to US$ 150 million by 2031, at a CAGR of 8.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 116
The global Biolayer Interferometry (BLI) Instruments market size was US$ 86.6 million in 2024 and is forecast to a readjusted size of US$ 150 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 66
The global market for Biolayer Interferometry (BLI) Instruments was valued at US$ 86.6 million in the year 2024 and is projected to reach a revised size of US$ 150 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Published: 2025-03-10
Pages: 82
Valued at US$ 93.8 million in 2024, the global Biolayer Interferometry (BLI) Instruments market is forecast to reach US$ 150 million by 2030, at a CAGR of 8.1% during the forecast period.
Published: 2025-03-03
Pages: 129
Bio-Layer Interferometry (BLI) is a label-free, real-time monitoring optical detection technology, mainly used to analyze the interaction between biomolecules. BLI instruments detect the kinetic changes or concentration data of molecular interactions by monitoring the changes in the film thickness caused by the binding of biomolecules on the surface of the biosensor.
Published: 2024-09-04
Pages: 82
Bio-Layer Interferometry (BLI) is a label-free, real-time monitoring optical detection technology, mainly used to analyze the interaction between biomolecules. BLI instruments detect the kinetic changes or concentration data of molecular interactions by monitoring the changes in the film thickness caused by the binding of biomolecules on the surface of the biosensor.
Published: 2024-09-04
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now